sl 84.0418 has been researched along with glucagon in 1 studies
Studies (sl 84.0418) | Trials (sl 84.0418) | Recent Studies (post-2010) (sl 84.0418) | Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) |
---|---|---|---|---|---|
11 | 1 | 0 | 26,039 | 1,498 | 3,054 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berlin, I; Blacker, C; Cesselin, F; Chalon, S; Fuseau, E; Landault, C; Puech, AJ; Rosenzweig, P | 1 |
1 trial(s) available for sl 84.0418 and glucagon
Article | Year |
---|---|
Reduction of hyperglycemia after oral glucose load by the new alpha 2-adrenergic receptor antagonist SL 84.0418 in healthy subjects.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adult; Blood Glucose; C-Peptide; Catecholamines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Glipizide; Glucagon; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Indoles; Insulin; Male; Pyrroles; Reference Values | 1994 |